A Study in a Human Laboratory Model of Smoking Behavior

NCT02641028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking

Interventions

DRUG: CERC-501
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC